
Invitae Corporation NVTA
Country |
|
IPO year |
2015 |
Industry |
Diagnostics research |
Stock Exchange |
NYSESPB |
Shares |
236 M |
Market Cap[1] |
$ 21.2 M |
EBITDA (LTM) |
- |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Other stocks of industry "Diagnostics research"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | ||
|
Biomerica
BMRA
|
$ 1.85 | 3.0 % | $ 5.39 M | Nasdaq Capital Market | ||
|
Myriad Genetics
MYGN
|
$ 3.98 | 4.82 % | $ 369 M | Nasdaq Global Select Market,SPB | ||
|
Pacific Biosciences of California
PACB
|
$ 1.73 | 0.73 % | $ 519 M | Nasdaq Global Select Market,SPB | ||
|
Neuronetics
STIM
|
$ 1.89 | 3.45 % | $ 125 M | Nasdaq Global Select Market | ||
|
Agilent Technologies
A
|
$ 172.97 | 0.07 % | $ 49.1 B | NYSE,SPB | ||
|
Charles River Laboratories International
CRL
|
$ 300.15 | 0.79 % | $ 14.9 B | NYSE,SPB | ||
|
Biodesix
BDSX
|
$ 23.66 | 3.0 % | $ 179 M | Nasdaq Global Market | ||
|
Burning Rock Biotech Limited
BNR
|
$ 12.9 | 6.78 % | $ 136 M | Nasdaq Global Market | ||
|
Bioventus
BVS
|
$ 13.3 | 0.94 % | $ 886 M | Nasdaq Global Select Market | ||
|
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | ||
|
DermTech
DMTK
|
- | -11.32 % | $ 2.94 M | Nasdaq Capital Market,SPB | ||
|
Co-Diagnostics
CODX
|
$ 0.65 | 11.61 % | $ 865 K | Nasdaq Capital Market | ||
|
Fulgent Genetics
FLGT
|
$ 19.81 | 1.57 % | $ 610 M | Nasdaq Global Market | ||
|
Surmodics
SRDX
|
- | - | $ 608 M | Nasdaq Global Select Market,SPB | ||
|
Illumina
ILMN
|
$ 262.54 | 0.3 % | $ 40.7 B | Nasdaq Global Select Market,SPB | ||
|
Syneos Health
SYNH
|
- | - | $ 4.46 B | Nasdaq Global Select Market,SPB | ||
|
Motus GI Holdings
MOTS
|
- | -34.28 % | $ 263 K | Nasdaq Global Select Market | ||
|
Renalytix AI plc
RNLX
|
- | 5.66 % | $ 22.7 M | Nasdaq Global Market | ||
|
Laboratory Corporation of America Holdings
LH
|
$ 317.95 | 0.09 % | $ 26.5 B | NYSE,SPB | ||
|
Psychemedics Corporation
PMD
|
- | -1.84 % | $ 15.3 M | Nasdaq Global Select Market | ||
|
Lantheus Holdings
LNTH
|
$ 99.7 | 0.03 % | $ 6.73 B | Nasdaq Global Select Market,SPB | ||
|
T2 Biosystems
TTOO
|
- | -39.35 % | $ 313 K | Nasdaq Global Select Market | ||
|
Meridian Bioscience
VIVO
|
- | - | $ 1.49 B | Nasdaq Global Select Market | ||
|
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market | ||
|
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | ||
|
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | ||
|
Anixa Biosciences
ANIX
|
$ 2.67 | 4.71 % | $ 86.7 K | Nasdaq Capital Market | ||
|
Medpace Holdings
MEDP
|
$ 618.47 | 1.94 % | $ 17.8 B | Nasdaq Global Select Market,SPB | ||
|
Heska Corporation
HSKA
|
- | - | $ 1.31 B | Nasdaq Capital Market,SPB | ||
|
Celcuity
CELC
|
$ 56.58 | 0.67 % | $ 2.65 B | Nasdaq Global Select Market | ||
|
HTG Molecular Diagnostics
HTGM
|
- | -20.0 % | $ 1.06 M | Nasdaq Capital Market | ||
|
Mettler-Toledo International
MTD
|
$ 1 622.29 | 0.12 % | $ 33.4 B | NYSE,SPB | ||
|
NeoGenomics
NEO
|
$ 16.65 | 2.19 % | $ 2.13 B | Nasdaq Global Select Market,SPB | ||
|
Neogen Corporation
NEOG
|
$ 11.81 | 0.73 % | $ 2.57 B | Nasdaq Global Select Market,SPB | ||
|
CareDx, Inc
CDNA
|
$ 64.0 | 3.07 % | $ 3.41 B | Nasdaq Global Market,SPB | ||
|
National Research Corporation
NRC
|
$ 20.15 | 3.33 % | $ 451 M | Nasdaq Global Select Market | ||
|
Danaher Corporation
DHR
|
$ 229.04 | 3.04 % | $ 163 B | NYSE,SPB | ||
|
Koninklijke Philips N.V.
PHG
|
$ 25.74 | 0.98 % | $ 24.4 B | NYSE | ||
|
Brainsway Ltd.
BWAY
|
$ 11.44 | 2.69 % | $ 389 M | Nasdaq Global Select Market | ||
|
Precipio
PRPO
|
$ 21.38 | 1.3 % | $ 34.3 M | Nasdaq Global Select Market | ||
|
RadNet
RDNT
|
$ 68.8 | 1.81 % | $ 5.17 B | Nasdaq Global Select Market | ||
|
Castle Biosciences
CSTL
|
$ 31.96 | 2.08 % | $ 926 M | Nasdaq Global Market,SPB | ||
|
Guardant Health
GH
|
$ 158.6 | 1.77 % | $ 19.9 B | Nasdaq Global Select Market,SPB | ||
|
Senseonics Holdings
SENS
|
$ 7.77 | 1.6 % | $ 324 M | NYSE American | ||
|
DarioHealth Corp.
DRIO
|
$ 4.82 | 0.97 % | $ 19.2 M | Nasdaq Capital Market | ||
|
DexCom
DXCM
|
$ 86.04 | 0.07 % | $ 33.6 B | Nasdaq Global Select Market,SPB | ||
|
IQVIA Holdings
IQV
|
$ 266.9 | 0.11 % | $ 45.9 B | NYSE,SPB | ||
|
Quotient Limited
QTNT
|
- | -11.32 % | $ 1.1 M | Nasdaq Global Select Market |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.